| Basics |
| Company: |
HilleVax, Inc. |
| IPO Date: |
April 29, 2022 |
| Sector: |
Healthcare |
| Industry: |
Biotech |
| Market Cap: |
$91.15M |
| Activated in VL: |
True |
| Average Daily Range |
| Avg Daily Range: |
$0.42 | 3.22%
|
| Avg Daily Range (30 D): |
$0.03 | 1.71%
|
| Avg Daily Range (90 D): |
$0.04 | 1.93%
|
| Institutional Daily Volume |
| Avg Daily Volume: |
.18M |
| Avg Daily Volume (30 D): |
.17M |
| Avg Daily Volume (90 D): |
.18M |
| Trade Size |
| Avg Trade Size (Sh.): |
106 |
| Avg Trade Size (Sh.) (30 D): |
130 |
| Avg Trade Size (Sh.) (90 D): |
131 |
| Institutional Trades |
| Total Inst.Trades: |
104 |
| Avg Inst. Trade: |
$1.88M |
| Avg Inst. Trade (30 D): |
$.53M |
| Avg Inst. Trade (90 D): |
$.53M |
| Avg Inst. Trade Volume: |
.13M |
| Avg Inst. Trades (Per Day): |
1 |
| Market Closing Trades |
| Avg Closing Trade: |
$2.58M |
| Avg Closing Trade (30 D): |
$.53M |
| Avg Closing Trade (90 D): |
$.53M |
| Avg Closing Volume: |
187.3K |
|
|
|
|
| News |
Jul 19, 2024 @ 3:02 PM
HilleVax, Inc. (HLVX) Investigation: Bronstein, Ge...
Source: Bronstein, Gewirtz & Grossman, Llc
|
Jul 14, 2024 @ 3:01 PM
HilleVax, Inc. (HLVX) Investigation: Bronstein, Ge...
Source: Bronstein, Gewirtz & Grossman, Llc
|
Jul 9, 2024 @ 8:45 PM
(HLVX) - Analyzing HilleVax's Short Interest - Hil...
Source: Benzinga Insights, Benzinga Staff Writer
|
Jul 9, 2024 @ 8:47 AM
HilleVax shares target violently slashed by Stifel...
Source: Emilio Ghigini
|
Jul 8, 2024 @ 1:43 PM
Why Is HilleVax Stock Trading Lower On Monday? - H...
Source: Vandana Singh
|
| Financials |
| |
TTM |
Q2 2024 |
Q1 2024 |
|
Basic EPS
|
$-.52
|
$-.83
|
$-.97
|
|
Diluted EPS
|
$-.52
|
$-.83
|
$-.97
|
|
Revenue
|
$ M
|
$ M
|
$ M
|
|
Gross Profit
|
$
|
$
|
$
|
|
Net Income / Loss
|
$ -25.82M
|
$ -40.67M
|
$ -46.83M
|
|
Operating Income / Loss
|
$ -26.38M
|
$ -42.96M
|
$ -49.8M
|
|
Cost of Revenue
|
$
|
$
|
$
|
|
Net Cash Flow
|
$ -4.68M
|
$ -32.63M
|
$ -75.6M
|
|
PE Ratio
|
|
|
|
|
